Internal Medicine, Endocrinology, Diabetes, & Metabolism · Joliet, IL
NPI
1396762316
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2100 Glenwood Ave
Joliet, IL, 60435
Phone (630) 789-4910
Groups this clinician bills Medicare through
Medicare paid, 2024
$132K
15,599 services
Medicare patients, 2024
567
Average age 73
Drug cost, 2024
$4.7M
10,713 prescriptions
Company payments, 2025
$117K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Babak Pazooki was code J0897 (injection, denosumab, 1 mg), 1,440 times for 16 patients. In total Babak Pazooki billed 15,599 services in 53 codes, and Medicare paid $132K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,440 | 16 | $20.07 | $29K |
| 83036 Blood Count | Office | 422 | 280 | $9.48 | $4,001 |
| 36415 Venipuncture Blood Collection | Office | 410 | 303 | $8.61 | $3,531 |
| 99214 Office E&M - Established | Office | 398 | 316 | $87.10 | $35K |
| 82570 Clinical Chemistry | Office | 262 | 212 | $5.08 | $1,331 |
| 82043 Clinical Chemistry | Office | 260 | 212 | $5.66 | $1,472 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 200 | 188 | $13.34 | $2,667 |
| 84443 Clinical Chemistry | Office | 190 | 135 | $16.46 | $3,127 |
| 84439 Clinical Chemistry | Office | 187 | 133 | $8.84 | $1,653 |
| 99215 Office E&M - Established | Office | 157 | 120 | $140.59 | $22K |
| 95251 Test - Miscellaneous | Office | 121 | 83 | $25.01 | $3,027 |
| 80048 Clinical Chemistry | Office | 117 | 107 | $8.22 | $962 |
| 99204 Office E&M - New | Office | 64 | 64 | $125.69 | $8,044 |
| 96372 Injection Administration | Office | 59 | 19 | $9.54 | $563 |
| 80053 Clinical Chemistry | Office | 40 | 36 | $10.35 | $414 |
By year: 2022 $128K for 14,073 services; 2023 $131K for 12,079 services; 2024 $132K for 15,599 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 422 | 280 | $9.48 | $4,001 |
| 36415 Venipuncture Blood Collection | 410 | 303 | $8.61 | $3,531 |
| 82570 Clinical Chemistry | 262 | 212 | $5.08 | $1,331 |
| 82043 Clinical Chemistry | 260 | 212 | $5.66 | $1,472 |
| 84443 Clinical Chemistry | 190 | 135 | $16.46 | $3,127 |
| 84439 Clinical Chemistry | 187 | 133 | $8.84 | $1,653 |
| 80048 Clinical Chemistry | 117 | 107 | $8.22 | $962 |
| 80053 Clinical Chemistry | 40 | 36 | $10.35 | $414 |
| 83970 Clinical Chemistry | 31 | 29 | $40.45 | $1,254 |
| 82306 Clinical Chemistry | 25 | 23 | $29.01 | $725 |
Medicare prescription drug claims, 2024
In 2024, the drug Babak Pazooki prescribed most often to Medicare patients was Metformin Hcl, with 932 prescriptions and refills. In total Babak Pazooki wrote 10,713 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 932 | 2,672 | 314 | $8,067 |
| Levothyroxine Sodium Generic | 915 | 2,660 | 296 | $12K |
| Atorvastatin Calcium Generic | 789 | 2,326 | 285 | $7,907 |
| Ozempic Semaglutide | 513 | 1,021 | 134 | $968K |
| Glimepiride Generic | 484 | 1,367 | 173 | $5,367 |
| Farxiga Dapagliflozin Propanediol | 452 | 1,067 | 148 | $586K |
| Metformin Hcl Er Metformin Hcl | 398 | 1,111 | 144 | $2,699 |
| Lisinopril Generic | 328 | 971 | 122 | $1,909 |
| Losartan Potassium Generic | 308 | 892 | 114 | $2,956 |
| Mounjaro Tirzepatide | 289 | 421 | 60 | $449K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 283 | 677 | 100 | $59K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 269 | 613 | 86 | $480K |
| Glipizide Generic | 260 | 738 | 92 | $3,884 |
| Rosuvastatin Calcium Generic | 255 | 726 | 85 | $3,728 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 250 | 581 | 76 | $182K |
Brand drugs: 4,210 claims; generic drugs: 5,783 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Babak Pazooki $117K ($117K in general payments such as food, travel and fees) from 14 companies. The largest payer was Lilly USA, LLC with $52K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.